These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17504335)

  • 1. Chemoprevention of colorectal cancer - a new target needed?
    Spychalski M; Dziki L; Dziki A
    Colorectal Dis; 2007 Jun; 9(5):397-401. PubMed ID: 17504335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point.
    Arber N
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1852-7. PubMed ID: 18708371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer.
    Schrör K
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):473-84. PubMed ID: 22122764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemoprevention of colorectal cancer].
    Herszényi L; Juhász M; Prónai L; Tulassay Z
    Orv Hetil; 2004 Mar; 145(12):603-10. PubMed ID: 15119114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2: a molecular target for colorectal cancer prevention.
    Brown JR; DuBois RN
    J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of colorectal cancer: feasibility in everyday practice?
    Herszényi L; Farinati F; Miheller P; Tulassay Z
    Eur J Cancer Prev; 2008 Nov; 17(6):502-14. PubMed ID: 18941372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib: new indication. Colorectal cancer: no preventive benefit.
    Prescrire Int; 2006 Feb; 15(81):13-5. PubMed ID: 16548099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprophylaxis in colorectal cancer: current concepts and a practical algorithm for use.
    Tan VP; Chan P; Hung IF; Pang R; Wong BC
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S57-66. PubMed ID: 20374032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?
    Manzano A; Pérez-Segura P
    ScientificWorldJournal; 2012; 2012():327341. PubMed ID: 22649288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of colorectal cancer.
    Das D; Arber N; Jankowski JA
    Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.
    Hilmi I; Goh KL
    Chin J Dig Dis; 2006; 7(1):1-6. PubMed ID: 16412030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coxibs: pharmacology, toxicity and efficacy in cancer clinical trials.
    Garcia Rodriguez LA; Cea-Soriano L; Tacconelli S; Patrignani P
    Recent Results Cancer Res; 2013; 191():67-93. PubMed ID: 22893200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Colorectal cancer chemoprevention].
    Starzyńka T; Wasilewicz MP
    Pol Merkur Lekarski; 2007 Jul; 23(133):70-3. PubMed ID: 18051834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of colorectal neoplasia: advances and controversies (the COX-2 story).
    Bresalier RS
    Curr Opin Gastroenterol; 2007 Jan; 23(1):44-7. PubMed ID: 17133084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of colorectal neoplasia: the potential for personalized medicine.
    Arber N; Levin B
    Gastroenterology; 2008 Apr; 134(4):1224-37. PubMed ID: 18395100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience.
    Fujimura T; Ohta T; Oyama K; Miyashita T; Miwa K
    World J Gastroenterol; 2006 Mar; 12(9):1336-45. PubMed ID: 16552798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 (COX-2) in carcinogenesis and selective COX-2 inhibitors for chemoprevention in gastrointestinal cancers.
    Fujimura T; Ohta T; Oyama K; Miyashita T; Miwa K
    J Gastrointest Cancer; 2007; 38(2-4):78-82. PubMed ID: 19031117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
    Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.